Pulmonx Net Profit Margin 2019-2024 | LUNG
Pulmonx net profit margin from 2019 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Pulmonx Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2024-12-31 | $0.08B | $-0.06B | -66.67% |
| 2024-09-30 | $0.08B | $-0.06B | -72.15% |
| 2024-06-30 | $0.08B | $-0.06B | -75.32% |
| 2024-03-31 | $0.07B | $-0.06B | -80.82% |
| 2023-12-31 | $0.07B | $-0.06B | -88.41% |
| 2023-09-30 | $0.07B | $-0.06B | -93.85% |
| 2023-06-30 | $0.06B | $-0.06B | -98.36% |
| 2023-03-31 | $0.06B | $-0.06B | -101.72% |
| 2022-12-31 | $0.05B | $-0.06B | -109.26% |
| 2022-09-30 | $0.05B | $-0.06B | -109.43% |
| 2022-06-30 | $0.05B | $-0.05B | -103.85% |
| 2022-03-31 | $0.05B | $-0.05B | -104.00% |
| 2021-12-31 | $0.05B | $-0.05B | -102.08% |
| 2021-09-30 | $0.04B | $-0.05B | -102.27% |
| 2021-06-30 | $0.04B | $-0.04B | -92.86% |
| 2021-03-31 | $0.03B | $-0.04B | -111.76% |
| 2020-12-31 | $0.03B | $-0.03B | -94.12% |
| 2020-06-30 | $0.02B | $-0.02B | -104.55% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.148B | $0.084B |
| Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.774B | 53.56 |
| Hims & Hers Health (HIMS) | United States | $11.630B | 121.74 |
| Tempus AI (TEM) | United States | $10.119B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.616B | 72.12 |
| IRhythm Technologies (IRTC) | United States | $4.348B | 0.00 |
| Privia Health (PRVA) | United States | $2.829B | 212.00 |
| Enovis (ENOV) | United States | $1.955B | 12.10 |
| Clover Health Investments (CLOV) | United States | $1.926B | 0.00 |
| Schrodinger (SDGR) | United States | $1.732B | 0.00 |
| Phreesia (PHR) | United States | $1.434B | 0.00 |
| Azenta (AZTA) | United States | $1.154B | 53.74 |
| Omnicell (OMCL) | United States | $1.154B | 20.35 |
| 10x Genomics (TXG) | United States | $1.016B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.568B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.530B | 0.00 |
| Talkspace (TALK) | United States | $0.512B | 152.00 |
| Veradigm (MDRX) | United States | $0.466B | 0.00 |
| Standard BioTools (LAB) | United States | $0.387B | 0.00 |
| TruBridge (TBRG) | United States | $0.381B | 850.00 |
| Claritev (CTEV) | United States | $0.344B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.279B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.215B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.200B | 0.00 |
| American Well (AMWL) | United States | $0.106B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.094B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.092B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.081B | 0.00 |
| CareCloud (CCLD) | United States | $0.080B | 3.03 |
| 111 (YI) | China | $0.064B | 0.00 |
| HeartBeam (BEAT) | United States | $0.063B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.062B | 0.00 |
| Outset Medical (OM) | United States | $0.042B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.038B | 0.00 |
| Zhongchao (ZCMD) | China | $0.030B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.015B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |